Update on thrombolytic agents: emerging options for AMI managementCALIFF, R. M; MASERI, A.European heart journal. 1997, Vol 18, Num DEC, issn 0195-668X, 37 p., SUPFConference Proceedings

Clinical trial results with a new plasminogen activatorBODE, C; PETER, K; MOSER, M et al.European heart journal. 1997, Vol 18, Num DEC, pp F17-F21, issn 0195-668X, SUPFConference Paper

The concept of equivalence and its application to the assessment of thrombolytic effectsHAMPTON, J. R.European heart journal. 1997, Vol 18, Num DEC, pp F22-F27, issn 0195-668X, SUPFConference Paper

The GUSTO trial and the open artery theoryCALIFF, R. M.European heart journal. 1997, Vol 18, Num DEC, pp F2-F10, issn 0195-668X, SUPFConference Paper

Targeting new thrombolytic regimens at specific patient groups : implications for research and cost-containmentMASERI, A; ANDREOTTI, F.European heart journal. 1997, Vol 18, Num DEC, pp F28-F35, issn 0195-668X, SUPFConference Paper

Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activatorSMALLING, R. W.European heart journal. 1997, Vol 18, Num DEC, pp F11-F16, issn 0195-668X, SUPFConference Paper